Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | EXP | | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of EOLA2 mRNA | CTD | PMID:24763279 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of EOLA2 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | Eola2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of EOLA2 mRNA | CTD | PMID:30816183 and PMID:32528016 | cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of EOLA2 mRNA | CTD | PMID:24376830 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of EOLA2 mRNA | CTD | PMID:25562108 and PMID:27989131 | dibutyl phthalate | decreases expression | ISO | Eola2 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of EOLA2 mRNA | CTD | PMID:21266533 | furan | increases methylation | ISO | Eola2 (Rattus norvegicus) | 6480464 | furan results in increased methylation of EOLA2 gene | CTD | PMID:22079235 | glafenine | increases expression | ISO | Eola2 (Rattus norvegicus) | 6480464 | Glafenine results in increased expression of EOLA2 mRNA | CTD | PMID:24136188 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of EOLA2 mRNA | CTD | PMID:23649840 | oxaliplatin | multiple interactions | ISO | Eola2 (Rattus norvegicus) | 6480464 | [Oxaliplatin co-treated with Topotecan] results in increased expression of EOLA2 mRNA | CTD | PMID:25729387 | paracetamol | increases expression | ISO | Eola2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of EOLA2 mRNA | CTD | PMID:33387578 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of EOLA2 mRNA | CTD | PMID:22714537 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of EOLA2 mRNA | CTD | PMID:23557933 | silicon dioxide | increases expression | ISO | Eola2 (Rattus norvegicus) | 6480464 | Silicon Dioxide results in increased expression of EOLA2 mRNA | CTD | PMID:18685790 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of EOLA2 mRNA | CTD | PMID:31533062 | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of EOLA2 mRNA | CTD | PMID:34973136 | topotecan | increases expression | ISO | Eola2 (Rattus norvegicus) | 6480464 | Topotecan results in increased expression of EOLA2 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | ISO | Eola2 (Rattus norvegicus) | 6480464 | [Oxaliplatin co-treated with Topotecan] results in increased expression of EOLA2 mRNA | CTD | PMID:25729387 | |